个人简历

研究员、博士生导师。天津中医药大学“引进人才”，曾任美国佐治亚州立大学助理教授。2008年沈阳药科大学-日本京都药科大学联合培养博士，2008-2018年在美国俄克拉荷马大学和佐治亚州立大学工作。

研究领域

""1.中药治疗心血管疾病和代谢性疾病\r
2.肠道菌群对心血管系统的调控作用\r
3.现代中药分子靶点研究。通过构建分子靶点-细胞-离体器官-整体动物-临床样本综合评价体系，开发治疗动脉粥样硬化、高血压、心脏病等心血管疾病的药物""""

近期论文

Wang QL, Zou MH. Measurement of Reactive Oxygen Species (ROS) and Mitochondrial ROS in AMPK knockout Mice Blood Vessels. Methods in Molecular Biology. AMPK: Methods and Protocol. 2018. 1732: 507-517. Springer (著作)\r
\r
Wang QL, Wu SN, Zhu HP, et al. Deletion of PRKAA triggers mitochondrial fission by inhibiting the autophagy-dependent degradation of DNM1L. Autophagy. 2017, 13(2): 404-422. (IF：11.10)\r
3. Wang QL#, Zhang M#, Gloria T, et al. Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission. Diabetes. 2017, 66(1): 193-205. (IF：7.273)\r
\r
Lin Li#, Dongli Yang#, Jinghao Li, Lu Niu, Ye Chen, Xin Zhao, Patrick Kwabena Oduro, Chun Wei, Zongpei Xu, Qilong Wang*,Yuhong Li*. Investigation of Cardiovascular Protective Effect of Shenmai Injection by Network Pharmacology and Pharmacological Evaluation. BMC Complementary Medicine and Therapies. 2020, 20(1): 112\r
DOI: 10.1186/s12906-020-02905-8\r
\r
Patrick Kwabena Oduro, Jingmei Fang, Lu Niu, Yuhong Li, Lin Li, Xin Zhao, Qilong Wang*. Pharmacological management of vascular endothelial dysfunction in diabetes: TCM and western medicine compared based on biomarkers and biochemical parameters. Pharmacological Research. 2020, May 17, 104893\r
DOI: 10.1016/j.phrs.2020.104893\r